BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3660414)

  • 1. Changes in ACh levels in the rat brain during subacute administration of diisopropylfluorophosphate.
    Lim DK; Porter AB; Hoskins B; Ho IK
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):477-89. PubMed ID: 3660414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the involvement of presynaptic cholinergic functions in tolerance to diisopropylfluorophosphate.
    Lim DK; Hoskins B; Ho IK
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):465-76. PubMed ID: 3660413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
    Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.
    Harris L; Stitcher D
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):64-9. PubMed ID: 6493352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis.
    Toide K; Arima T
    Eur J Pharmacol; 1989 Dec; 173(2-3):133-41. PubMed ID: 2625133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contractile responses of tracheal smooth muscle in organophosphate-treated swine: 1. Agonist changes.
    Murali Mohan P; Huang Saunders HM; Yang CM; Dwyer TM; Farley JM
    J Auton Pharmacol; 1988 Jun; 8(2):93-106. PubMed ID: 2902099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with diisopropylfluorophosphate increases dopamine turnover in the striatum of the rat.
    Potter PE; Hadjiconstantinou M; Rubenstein JS; Neff NH
    Eur J Pharmacol; 1984 Nov; 106(3):607-11. PubMed ID: 6519178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DFP on iridic metabolism and release of acetylcholine and on pupillary function in the rat.
    Mattio TG; Richardson JS; Giacobini E
    Neuropharmacology; 1984 Oct; 23(10):1207-14. PubMed ID: 6521855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of tolerance development to diisopropylfluorophosphate.
    Lim DK; Fernando JC; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1987 Feb; 26(2):281-6. PubMed ID: 3575352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diisopropylfluorophosphate inhibits choline efflux from the perfused rat hemidiaphragm.
    Millington WR; Myers AC; Bierkamper GG
    Eur J Pharmacol; 1985 Sep; 115(1):37-44. PubMed ID: 4043234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in presynaptic release of acetylcholine during development of tolerance to the anticholinesterase, DFP.
    Russell RW; Booth RA; Jenden DJ; Roch M; Rice KM
    J Neurochem; 1985 Jul; 45(1):293-9. PubMed ID: 3998726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of diisopropylfluorophosphate (DFP) toxicity and tolerance in rats.
    Lim DK; Hoskins B; Ho IK
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):399-418. PubMed ID: 6856947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
    Tien LT; Fan LW; Ma T; Loh HH; Ho IK
    J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of diisopropylfluorophosphate and of diacetylmonoxime on acetylcholine levels and on cholinesterase activity in the central nervous system.
    Molinengo L; Orsetti M
    Arch Int Pharmacodyn Ther; 1988; 295():17-27. PubMed ID: 3245732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective breeding for differences in cholinergic function: pre- and postsynaptic mechanisms involved in sensitivity to the anticholinesterase, DFP.
    Overstreet DH; Russell RW; Crocker AD; Schiller GD
    Brain Res; 1984 Mar; 294(2):327-32. PubMed ID: 6704730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
    Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
    J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diisopropylfluorophosphate on brain acetylcholinesterase, butyrylcholinesterase, and neurotoxic esterase in rats.
    Lim DK; Hoskins B; Ho IK
    Biomed Environ Sci; 1989 Sep; 2(3):295-304. PubMed ID: 2610946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of mu-opioid receptors in development of tolerance to diisopropylfluorophosphate (DFP).
    Tien LT; Fan LW; Ma T; Loh HH; Ho IK
    J Toxicol Sci; 2005 Feb; 30(1):43-59. PubMed ID: 15800401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    Brain Res; 1983 Jun; 268(2):315-20. PubMed ID: 6871685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of uptake of [14C]valine into protein in the development of tolerance to diisopropylphosphorofluoridate (DFP) toxicity.
    Gupta RC; Dettbarn WD
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):551-60. PubMed ID: 3726875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.